SecBot SecBot
PRESS-RELEASE ·Filed May 19, 2026

RMD

Resmed, Inc.
BEARISH
Impact 5/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The miss breaks 4 quarters of beats, eroding the momentum narrative. Watch the William Blair conference (June 2) for any FY guidance color, a lower FY guide would compound the miss.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$209.14
T+0 close · May 19, 2026 · via day close
Latest settled
+7.33%
T+60 · $224.46
Vs SPY
+2.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 20 $209.14entry
  2. T+1 · 6mo ago −0.14%α −0.33% · $208.85
  3. T+5 · 6mo ago −2.83%α −4.63% · $203.22
  4. T+20 · 5mo ago −10.92%α −10.88% · $186.29
  5. T+60 · 3mo ago +7.33%α +2.59% · $224.46

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Resmed reports fiscal Q3 2026 EPS of $2.86, a 1.4% miss vs consensus of $2.90. This is a modest negative relative to expectations for a med-tech bellwether, though absolute profit levels remain solid.

Key Financial Metrics

EPS
$2.86
est $2.90 · -1.4%
Revenue
$1.5B
est $1.5B · 0.0%
Rating
miss

Key Facts

  • EPS of $2.86 missed consensus estimate of $2.90 by $0.04 (1.4% miss)
  • Street-convention EPS reversed a multi-quarter beat streak where prior 4 quarters beat consensus by 2.4-4.5%
  • Revenue of $1.46B matched consensus (in-line, per provided context; no explicit beat/miss figure stated)
  • No guidance change was provided; filing is an earnings miss without a mitigating guidance raise

Financial Impact

Miss of $0.04/share vs consensus; revenue in-line at $1.46B

epsrevenue

Risk Factors

  • EPS miss breaks positive surprise momentum, likely to pressure near-term valuation multiple
  • No explicit guidance provided in this release; ambiguity around whether this was a one-quarter noise or a trend shift

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
62% bullish (26 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3297946

Track record

19 reports on RMD

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 Now $238.19 +1.74% settles Dec 9
  2. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  3. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
  4. Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
  5. Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
  6. Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
  7. Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
  9. Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (11h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026